🇺🇸 ITV plc (ITVPY) ITV plc, – M&A Call – Slideshow
🇺🇸 ITV plc (ITVPY) ITV plc, – M&A Call – Slideshow Source: seekingalpha Country: United States
North America
Corporate earnings, M&A, IPOs, and business developments across North American markets.
🇺🇸 Veradermics, Incorporated (MANE) Discusses Positive Female Results From Phase II Study of VDPHL01 for Pattern Hair Loss – Slideshow
🇺🇸 Veradermics, Incorporated (MANE) Discusses Positive Female Results From Phase II Study of VDPHL01 for Pattern Hair Loss – Slideshow Source: seekingalpha Country: United States
🇺🇸 ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Hub Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – HUBG
🇺🇸 NEW YORK, July 18, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of purchasers of securities of Hub Group, Inc. (NASDAQ: HUBG) between April 28, 2023 and May 11, 2026, inclusive (the “Class Period”), of the important August 28, 2026 lead plaintiff deadline . Source: globenewswire … Read more
🇺🇸 ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Verra Mobility Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – VRRM
🇺🇸 NEW YORK, July 18, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Verra Mobility Corporation (NASDAQ: VRRM) between February 24, 2026 and May 26, 2026, inclusive (the “Class Period”), of the important August 4, 2026 lead plaintiff deadline. Source: globenewswire Country: United … Read more
🇺🇸 4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population
🇺🇸 EMERYVILLE, Calif., July 18, 2026 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced positive 2-year data from the PRISM Phase 2b clinical trial evaluating 4D-150 in … Read more
🇺🇸 ColestZen Official Launch 2026 | Cholesterol Support Capsules Available in USA, UK, CA & AU Market By Colestzen Supplement.
🇺🇸 ColestZen Official Store announces ColestZen Supplement, formulated with carefully selected ingredients to support healthy cholesterol, support healthy blood sugar levels already within the normal range, and promote everyday wellness as part of a balanced lifestyle. ColestZen Official Store announces ColestZen Supplement, formulated with carefully selected ingredients to support healthy cholesterol, support healthy blood sugar … Read more
🇺🇸 Pudu Robotics präsentiert auf der WAIC 2026 seinen physischen Agenten nach dem Prinzip „One Brain, Multiple Embodiments”
🇺🇸 SHANGHAI, 18. Juli 2026 /PRNewswire/ — Pudu Robotics, der weltweit führende Anbieter von Servicerobotern für den gewerblichen Einsatz, veranstaltete heute am Eröffnungstag der World Artificial Intelligence Conference (WAIC) 2026 in Shanghai sein Pudu AI Technology Briefing. Im Rahmen der… Source: prnewswire Country: United States
🇺🇸 REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting
🇺🇸 One-time gene therapy treatment with sura-vec demonstrated long-term efficacy at similar doses to those being evaluated in ongoing late-stage studies: Stable to improved vision through 5 years in wet AMD patients who required frequent anti-VEGF injections prior to one-time sura-vec; no… Source: prnewswire Country: United States
🇺🇸 Veritone Deadline: VERI Investors Have Opportunity to Lead Veritone, Inc. Securities Fraud Lawsuit
🇺🇸 NEW YORK, July 18, 2026 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Veritone, Inc. (NASDAQ: VERI) between October 14, 2025 and April 14, 2026, inclusive (the “Class Period”), of the important July 20, 2026 lead plaintiff… Source: prnewswire Country: United States
🇺🇸 PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit
🇺🇸 NEW YORK, July 18, 2026 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Insulet Corporation (NASDAQ: PODD) between February 21, 2025 and May 26, 2026, inclusive (the “Class Period”), of the important August 31, 2026 lead plaintiff… Source: prnewswire Country: United States